North Star Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

North Star Investment Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$2K	–	1045
2019 Q1	$2K	Hold	500	–	–	﹤0.01%	1012
2018 Q4	$2K	Buy	500 +200	+67%	+$1.39K	﹤0.01%	998
2018 Q3	$3K	Hold	300	–	–	﹤0.01%	1008
2018 Q2	$2K	Hold	300	–	–	﹤0.01%	1045
2018 Q1	$2K	Hold	300	–	–	﹤0.01%	1024
2017 Q4	$3K	Buy	+300	New	+$1.96K	﹤0.01%	980

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

North Star Investment Management's INSY Position: Q2 2019 in Review

North Star Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 500 shares — an estimated $2K sold.

North Star Investment Management first reported a position in INSY in Q4 2017 and held it in 6 quarters. The position peaked at $3K in Q3 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

North Star Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
North Star Investment Management sold 500 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $2K.
North Star Investment Management first reported a position in Insys Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
North Star Investment Management's Insys Therapeutics, Inc. position peaked at $3K in Q3 2018.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on North Star Investment Management's 13F filing for Q2 2019, filed 15 Jul 2019.